Dr Jorge de la Rosa

Postdoctoral Fellow

Alumni

This person is a member of Sanger Institute Alumni.

Jorge’s current work is focused on the identification and charactetization of new driver genes and therapeutic targets in human cancers by performing transposon- and CRISPR/Cas9-based screens. I am particularly interested in understanding the molecular mechanims driving human prostate cancer progression and identifying new prostate cancer vulnerabilities that can be exploited therapeutically.

My timeline

• FEBS Postdoctoral Fellow, Wellcome Trust Sanger Institute, UK.

• PhD in Biochemistry and Molecular Biology, University of Oviedo, Spain.

• BSc in Biology, University of Oviedo, Spain.